Abstract
Background/Objectives: Reverse total shoulder arthroplasty (RTSA), a commonly performed procedure in elderly patients with osteoarthritis, is frequently complicated by postoperative infections—primarily caused by Cutibacterium acnes and coagulase-negative staphylococci (CoNS)—which remain a major clinical challenge. While standard antiseptic skin protocols can reduce the bacterial load at the surgical site, they often fail to achieve complete eradication, particularly with C. acnes, a resident species of the shoulder microbiome. Recent evidence indicates that intraoperative povidone–iodine irrigation is effective in significantly decreasing microbial burden; however, a thorough characterization of the virulence factors of the isolated strains remains essential. Methods: A total of 187 clinical strains isolated immediately after RTSA were characterized with respect to their antibiotic resistance profiles and biofilm-forming capacity, and the impact of intraoperative povidone–iodine irrigation on the reduction in bacteria that express these virulence traits was evaluated. Results: Of the 120 C. acnes isolates, 97.67% were susceptible to the tested antimicrobial agents, while only 3.33% exhibited resistance, specifically to clindamycin. In contrast, 53% of CoNS isolates were classified as susceptible, whereas the remaining 47% demonstrated multidrug resistance. Biofilm production was detected in 24% (29/120) of C. acnes and 39% (25/64) of CoNS isolates, with a statistically significant reduction observed after irrigation only for C. acnes. No association was found between biofilm formation and clindamycin resistance in C. acnes, likely due to the low number of resistant isolates. Conversely, among CoNS, a correlation was observed, with the 17.2% of biofilm-producing strains also exhibiting resistance to antimicrobial agents. Conclusions: Notwithstanding the presence of these virulence factors, povidone–iodine irrigation proved effective in substantially reducing the number of bacterial isolates recovered at the surgical site without selecting for strains with enhanced pathogenicity. Notably, the majority of resistant bacteria were detected prior to intraoperative irrigation. This intraoperative procedure may be a key approach to reducing prosthetic joint infections frequently caused by more virulent pathogens, which are unlikely to be selected following this disinfection strategy.
Keywords: povidone-iodine, susceptibility pattern, biofilm production, coagulase-negative staphylococci, Cutibacterium acnes, disinfection protocol
1. Introduction
Reverse total shoulder arthroplasty (RTSA) is a widely used procedure to restore quality of life in elderly patients suffering from osteoarthritis and other shoulder conditions, such as rotator cuff tear arthropathy and complex proximal humeral fractures [1,2]. Due to its anatomical location, the shoulder area has a different microbiome compared to the knee and hip, with Cutibacterium acnes being the most prevalent, followed by Gram-positive cocci [3,4]. Although postoperative infections are relatively rare, prosthetic joint infections (PJIs) can occur, with reported incidence rates of approximately 1–3% across different studies [1,4,5]. The literature consistently identifies C. acnes as the most frequently isolated pathogen, followed by Staphylococcus aureus and coagulase-negative staphylococci (CoNS), particularly S. epidermidis, S. hominis, and S. warneri [3,6,7,8,9]. Despite the lower incidence compared with hip and knee arthroplasty, shoulder PJIs are associated with relevant clinical and antimicrobial management burdens, especially in infections caused by biofilm-forming and antimicrobial-resistant organisms [10]. Patient-related factors, including age, sex, comorbidities, and skin colonization by C. acnes, have been associated with an increased risk of shoulder PJIs [4,11], and standardized diagnostic and classification criteria are widely adopted in clinical practice for their accurate identification [12].
Antibiotic prophylaxis and standard antiseptic techniques are designed to reduce the bacterial presence and load in the skin surrounding the arthroplasty site and to prevent contamination of the surgical area during the operation [6,13,14]. However, a significant limitation is that none of these methods is able to completely eliminate microbial presence or the subsequent risk of infection. For instance, a double skin preparation of the shoulder using chlorhexidine gluconate followed by povidone–iodine has proven effective in reducing CoNS, but it has limited impact on C. acnes [14]. Likewise, a systematic review concluded that chlorhexidine gluconate is generally ineffective against C. acnes, whereas hydrogen peroxide demonstrated greater efficacy in reducing its presence [15].
In recent years, additional strategies have been introduced to further reduce the risk of infection during arthroplasty. Among these, intraoperative irrigation with povidone–iodine has demonstrated efficacy following knee and hip prosthesis implantation [16,17,18]. More recently, its application immediately after RTSA has also shown promising results, leading to a reduction in both aerobic and anaerobic flora, as well as in their specific bacterial counts [19]. Despite these findings, a comprehensive characterization of the recovered bacterial strains—particularly with respect to their antimicrobial susceptibility profiles, biofilm-forming capabilities, and key virulence factors—remains limited. Therefore, the aim of the present study was to assess the antibiotic susceptibility and biofilm formation ability of 187 clinical isolates. Additionally, we sought to investigate whether intraoperative irrigation with povidone–iodine is also associated with a reduction in bacteria that express these virulence characteristics.
2. Results
2.1. Determination of the Antimicrobial Susceptibility Pattern of the Bacterial Isolates
Among the 120 C. acnes isolates, 97.67% were generally susceptible to the tested antimicrobial agents—namely Penicillin G, Ampicillin, Meropenem, Clindamycin, and Vancomycin (Figure 1)—while only 3.33% exhibited a resistant profile (Table 1). Notably, only four strains—originating from the same patient—were resistant to Clindamycin, with MICs of 0.75 µg/mL (n = 1), 1.0 µg/mL (n = 2), and 1.5 µg/mL (n = 1) (Figure 2). Of these, three were isolated before the intraoperative irrigation and one after. No statistically significant differences in resistance profiles were observed between isolates collected before and after irrigation.
Figure 1.
Representative images showing C. acnes isolate susceptible to Penicillin G (A), Meropenem (B), Clindamycin (C), and Vancomycin (D) on Schaedler agar plates, as determined by E-test.
Table 1.
Susceptibility pattern of C. acnes strains (n = 120) towards different antimicrobial agents, reported by MIC values, µg/mL, number of isolates, and percentages.
| Antimicrobial Agent | MIC Values (µg/mL) | Number of Isolates (%) |
|---|---|---|
| Penicillin G | ≤0.016 | 101 (84%) |
| 0.012–0.047 | 14 (12%) | |
| 0.06 | 5 (4%) | |
| Ampicillin | ≤0.016 | 98 (82%) |
| 0.023–0.047 | 10 (8%) | |
| 0.06–0.125 | 10 (8%) | |
| Meropenem | 0.002–0.008 | 70 (58%) |
| 0.012–0.047 | 34 (28%) | |
| 0.064 | 13 (11%) | |
| 0.125 | 3 (3%) | |
| Vancomycin | ≤0.064 | 23 (19%) |
| 0.125–0.38 | 74 (62%) | |
| 0.5–0.75 | 22 (18%) | |
| 1.5 | 1 (1%) | |
| Clindamycin | ≤0.016 | 68 (57%) |
| 0.023–0.047 | 34 (28%) | |
| 0.06–0.19 | 15 (12.5%) | |
| ≤1.5 | 4 (3.33%) |
Figure 2.
Representative images showing the C. acnes strains resistant to Clindamycin with different MIC values 0.75 µg/mL (A), 1 µg/mL (B) and 1.5 µg/mL (C) on Schaedler agar plates, as determined by E-test assay.
Among the CoNS isolates, 53% exhibited a fully susceptible profile, while the remaining 47% showed resistance to one or more antimicrobial agents. As illustrated in Figure 3, Methicillin resistance (MR)—defined by an Oxacillin MIC > 0.25 µg/mL—was detected in S. epidermidis (2 strains) and S. hominis (1 strain). Macrolide resistance, indicated by MICs ≥ 2 µg/mL for Erythromycin and/or Azithromycin, was observed in S. hominis (9 strains), S. epidermidis (4 strains), and S. warneri (2 strains). Fluoroquinolone resistance (MIC > 1 µg/mL for Moxifloxacin) was detected in S. warneri (2 strains), S. hominis (2 strains), S. epidermidis (1 strain), S. capitis (1 strain), and S. pasteuri (1 strain). Tetracycline resistance (MIC > 2 µg/mL) was identified in S. capitis (6 strains) and S. epidermidis (3 strains). Additionally, Gentamicin resistance (MIC > 4 µg/mL) was found in four strains—three S. hominis and one S. epidermidis—while resistance to Clindamycin (MIC > 2 µg/mL) was observed in two S. epidermidis, one S. hominis, and one S. warneri isolate. Notably, S. aureus and E. coli isolates were fully susceptible to all tested antimicrobial agents.
Figure 3.
Distribution of the resistance pattern of CoNS towards the different antimicrobial agents assayed.
As shown in Figure 4, most of the resistant strains were recovered prior to intraoperative irrigation. Although the procedure reduced the overall number of isolates, no statistically significant differences were observed in the distribution of susceptibility profiles between pre- and post-irrigation samples.
Figure 4.
Subdivision of CoNS strains according to their sensitivity (S) or resistance (R) to the assayed antimicrobial drugs, before (pre) and after (post) the irrigation procedure.
2.2. Determination of the Biofilm-Producing Capability of the Bacterial Isolates
Finally, another key virulence factor known to negatively influence patient outcomes—the ability to produce biofilm—was assessed in vitro using the Tissue Culture Plate (TCP) assay for both anaerobic and aerobic isolates, as previously described. Figure 5 shows representative wells from the assay, illustrating a strong biofilm-producing strain (Figure 5A) in comparison to non-biofilm-producing strains (Figure 5B,C).
Figure 5.
Representative images of crystal violet staining used to assess biofilm production: (A) strongly adherent, biofilm-producing strain; (B) weakly adherent strain; and (C) non-adherent, both considered non-biofilm-producing.
Among the C. acnes isolates, 29 out of 120 (24%) demonstrated biofilm-producing ability, classified as moderately or strongly adherent. The remaining 91 isolates (76%) were non-biofilm producers, displaying either a non-adherent or a weakly adherent profile. A higher number of antimicrobial-resistant and/or biofilm-forming isolates was recovered before intraoperative irrigation compared with post-irrigation samples. A comprehensive characterization of the C. acnes strains is provided in Table 2.
Table 2.
Summary of the biofilm producer and non-producer C. acnes isolates (as number of strains and percentage), before and after the povidone–iodine irrigation, reported by adhesion type.
| C. acnes (n = 120) | Type of Adhesion | PRE | POST | Fisher’s Exact Test |
|---|---|---|---|---|
| BF (n = 29) |
Strongly | 7 | 1 | p = 0.0250 |
| Moderate | 17 | 4 | ||
| Total | 24 (20%) | 5 (4%) | ||
| NBF (n = 91) |
Weakly | 20 | 12 | |
| Non-adherent | 33 | 26 | ||
| Total | 53 (44%) | 38 (32%) |
Abbreviation: Biofilm-forming: BF; Not biofilm-forming: NBF; Before povidone–iodine irrigation: PRE; After povidone–iodine irrigation: POST.
For the CoNS isolates, 39% exhibited biofilm production, while 61% were classified as non-biofilm-forming. Table 3 summarizes the distribution of moderate or strong biofilm-producing CoNS compared to weak or non-producers. In most species, the number of non-biofilm-producing strains exceeded that of biofilm producers. Exceptions included S. capitis and S. pasteuri, where biofilm producers were more prevalent, although both species were represented by a limited number of isolates. Moreover, also for these microorganisms, most isolates displayed a non-biofilm-forming profile compared with biofilm-producing isolates before intraoperative irrigation. Only a few biofilm-forming isolates were detected after irrigation, and these were represented by S. epidermidis, which was the most prevalent species among CoNS. A detailed species-level characterization of biofilm production before and after irrigation is reported in the Supplementary Materials (Table S1).
Table 3.
Summary of the biofilm producer and non-producer CoNS isolates (as number of strains and percentage), before and after the povidone–iodine irrigation, reported by adhesion type.
| CoNS (n = 64) | Type of Adhesion | PRE | POST | Fisher’s Exact Test |
|---|---|---|---|---|
| BF (n = 25) |
Strongly | 5 | 2 | p = 0.5052 |
| Moderate | 17 | 1 | ||
| Total | 22 (34%) | 3 (5%) | ||
| NBF (n = 39) |
Weakly | 25 | 4 | |
| Non-adherent | 6 | 4 | ||
| Total | 31 (48%) | 8 (13%) |
Abbreviation: Biofilm-forming: BF; Not biofilm-forming: NBF; Before povidone–iodine irrigation: PRE; After povidone–iodine irrigation: POST.
Regarding the other aerobic bacteria, the S. aureus isolate demonstrated biofilm production, while both E. coli isolates were not producers.
A statistically significant difference in biofilm production was observed among C. acnes strains prior to intraoperative irrigation (p = 0.0250), whereas no significant difference was found for CoNS (p = 0.5052), possibly reflecting the smaller number of CoNS isolates analyzed.
3. Discussion
The World Health Organization continues to update the list of antibiotic-resistant pathogens implicated in human infections and underscores the importance of addressing prosthetic joint infections (PJIs), including through the intraoperative use of povidone–iodine irrigation [20]. Several studies have supported the effectiveness of this approach in reducing infection rates following hip and knee arthroplasties [16,17,18]. More recently, its efficacy has also been demonstrated in RTSA, showing a reduction in both bacterial load and microbial diversity [19]. However, none of these studies conducted a full characterization of the isolated strains—when available—nor assessed whether the irrigation was associated with changes in their virulence factors. The aims of the present study were to determine the antimicrobial susceptibility patterns and biofilm production profiles of 187 clinical strains isolated from RTSA surgical sites, as well as to evaluate whether the intraoperative povidone–iodine irrigation could influence these virulence characteristics of the isolates.
C. acnes has gained increasing recognition in orthopedic surgery, not only in shoulder arthroplasty but also in procedures such as spine surgery. It is associated with PJIs, and the reported prevalence rates vary across the studies [21]. The current literature has described the susceptibility patterns of C. acnes to commonly used antimicrobial agents. Specifically, Baroudi et al. (2024) [21] reported high efficacy of penicillin, vancomycin, and cephalosporins. Núñez-Pereira et al. (2023) [13] highlighted the positive activity of rifamycin, while Ishida et al. (2008) [22] demonstrated that quinolones, tetracyclines, carbapenems, fusidic acid, and chloramphenicol were effective against this bacterium. Although considered a low-grade pathogen, C. acnes is generally susceptible to antimicrobials; however, recent studies have reported an increasing recovery of resistant strains. For instance, C. acnes has been reported as resistant to metronidazole, macrolides, trimethoprim/sulfamethoxazole, and clindamycin [21,23,24,25,26,27,28]. In the present study, we collected 120 intraoperative C. acnes isolates that were characterized for their antimicrobial susceptibility profiles. Our findings are in good agreement with those reported by other works as the only resistance observed—albeit in a small proportion of strains (~3%)—was to clindamycin, with MIC values ranging from 0.75 to 1.5 µg/mL [11,23,29,30]. Similarly, Broly et al. (2020) [31] reported clindamycin resistance in approximately 4% of C. acnes isolates, which were collected from both orthopedic surgery-related specimens and skin samples.
Additionally, aerobic Gram-positive—specifically CoNS and S. aureus—and Gram-negative bacteria, although rarely isolated, can serve as etiological agents of PJIs in the shoulder too. These microorganisms are well known for their resistance to a wide range of drugs [10,32]. In our study, we identified 64 CoNS, 1 S. aureus and 2 E. coli isolates directly from intraoperative swabs and tissue samples, all of which were characterized for their antimicrobial susceptibility testing profiles. Notably, 47% of the CoNS isolates exhibited resistance to one or more antimicrobial agents. In particular, 15/64 (23%) strains were resistant to macrolides, 9/64 (14%) to tetracyclines, 7/64 (11%) to fluoroquinolones, 4/64 (6%) to gentamicin and clindamycin, and 3/64 (5%) to methicillin, whereas the S. aureus and E. coli isolates were susceptible to all tested drugs. These findings are consistent with those reported by Coskun et al. (2024) [33], who showed that approximately 50% of isolates from orthopedic specimens were resistant to antimicrobials. In contrast, higher rates of methicillin-resistant CoNS and S. aureus were observed in their study [33]. Mitterer et al. (2022) [34] reported lower resistance rates (~17%) among the isolated microorganisms. However, consistent with our findings, S. epidermidis was the most prevalent CoNS species and exhibited resistance to multiple antibiotics, particularly tetracyclines, gentamicin, and fluoroquinolones [33,35]. Similarly, other authors [32] have also reported an increase in resistance to fluoroquinolones over recent years.
Despite the clinical relevance of PJIs, to the best of our knowledge, few studies have characterized the resistance profiles of CoNS species other than S. epidermidis and here S. warneri, S. hominis, and S. capitis were recovered from intraoperative clinical specimens. Among them, S. hominis was the most resistant species, with 83% of isolates showing resistance—particularly to macrolides, gentamicin, and fluoroquinolones; notably, one isolate was also identified as MR. In addition, 86% of S. capitis isolates were resistant to tetracyclines, while 14% of S. warneri isolates exhibited resistance to macrolides or fluoroquinolones. In a multicenter study, 215 CoNS strains causing PJIs were collected, with S. hominis identified as the most resistant species—particularly to ofloxacin, clindamycin, rifampicin, and trimethoprim/sulfamethoxazole—followed by S. haemolyticus [36]. The same authors also reported high resistance to fosfomycin in S. capitis (~67%) and S. warneri (~75%) [36]. De Vecchi et al. (2018) [37] and Ortega-Peña et al. (2019) [38] obtained a comparable pattern of resistance in CoNS—other than S. epidermidis.
Another challenging bacterial virulence factor is the ability to produce biofilm, as it enables pathogens to evade the host immune system and significantly reduces the effectiveness of infection treatment. In orthopedic surgery, this capability is well recognized in both C. acnes and CoNS [39,40,41]. However, most studies have focused on C. acnes isolates from the skin in the context of acne [42,43], despite its established role as a major component of the shoulder microbiome [44]. Eighty-five clinical strains of C. acnes were evaluated for their biofilm-forming capacity: the isolates were obtained from either skin swabs or deep surgical specimens, with the latter demonstrating a significantly higher level of biofilm production [44]. In another study, 14 strains from skin were subjected to biofilm production in vitro, and four of them displayed a greater biofilm formation [45]. Similarly, there is a paucity of literature analyzing in vitro biofilm production in CoNS clinical isolates specifically associated with orthopedic infections. For instance, Santos et al. (2022) [46] determined the production of biofilm by seven CoNS: S. epidermidis strains were strong producers, whereas variable profiles were noted for S. saprophyticus, S. capitis and S. lugdunensis. In a cross-sectional study, seventy-six strains were evaluated for biofilm production, and approximately 28% were identified as strong biofilm producers. Notably, these strains were not collected from deep surgical specimens [47]. In the present study, 29 out of 120 (24.2%) C. acnes isolates and 25 out of 64 (39.1%) CoNS isolates were identified as biofilm producers, exhibiting either strong or moderate adhesion. Among the CoNS, biofilm production was observed in 9 out of 22 S. epidermidis, 5 out of 9 S. capitis, and in both isolates of S. lugdunensis and S. pasteuri.
Regarding C. acnes, no association was observed between biofilm formation and clindamycin resistance. This finding is likely influenced by the limited number of clindamycin-resistant isolates detected in the present study but is in line with previous reports describing generally low rates of clindamycin resistance in C. acnes [23,31]. In contrast, for CoNS, such a correlation was evident: 11 out of 64 (17.2%) biofilm-forming strains exhibited antimicrobial resistance. Specifically, resistance was detected in two out of nine S. epidermidis, four out of five S. capitis, all four S. hominis, and one out of two S. pasteuri isolates. These findings are consistent with the existing literature, which shows that biofilm formation contributes to bacterial resistance to antibiotics in general [42,48,49,50], and particularly within orthopedic surgery [40,46,51,52]. In this context, Charalambous et al. (2022) [40] reported that CoNS, isolated from recurrent PJIs following failed hip and knee arthroplasties, exhibited increased antibiotic resistance associated with biofilm production. These observations are in line with the results presented here and with those of Koch et al. (2020) [51] and Tevell et al. (2017) [53], who specifically focused on S. epidermidis and S. capitis, respectively.
The last step was to evaluate whether the irrigation procedure contributed to the selection of bacterial strains with higher virulence—specifically, those exhibiting antimicrobial resistance and/or the ability to produce biofilm. Accordingly, the results provide a descriptive microbiological characterization of the recovered isolates, with specific reference to the limited number of CoNS strains. The results indicated that the higher number of strains isolated before irrigation, compared to those collected afterward, was associated with a significant proportion of antimicrobial-resistant and/or biofilm-producing isolates. Specifically, prior to intraoperative povidone–iodine irrigation, a total of 78/120 C. acnes and 53/64 CoNS were isolated. Among these, 3 C. acnes and 25 CoNS strains exhibited antimicrobial resistance, while 24 and 22 strains, respectively, demonstrated biofilm-forming capacity. In contrast, after the irrigation, only one C. acnes strain resistant to clindamycin was detected, along with five biofilm-forming strains. As for CoNS, five resistant and three biofilm-producing isolates were identified. It can be speculated that povidone–iodine, beyond its general antimicrobial activity, interferes with specific bacterial structures and functions, including membrane integrity, protein denaturation, and oxidative damage to cellular components. Experimental evidence suggests that povidone–iodine may also impair the synthesis and stability of extracellular polymeric substances, thereby affecting the early stages of biofilm development in staphylococci and C. acnes [41,54]. This mechanism may help eliminate pathogens at the surgical site before colonization of the implanted prosthesis occurs. These results confirm the efficacy of povidone–iodine irrigation in eliminating or reducing bacterial presence directly in the operative field without promoting the selection of more pathogenic strains. In this regard, specific clinical literature is currently lacking. However, some in vitro studies have shown that povidone–iodine is effective in reducing C. acnes counts and inhibiting biofilm formation by both staphylococci and C. acnes [55,56,57,58]. Additionally, the data obtained fit within a broader framework of environmental adaptation and phenotypic modulation. The variations observed in adhesion and biofilm assays may reflect microenvironment-dependent regulatory mechanisms and differences between planktonic and sessile bacterial populations, while also highlighting the inherent limitations of in vitro models in reproducing the complexity of the in vivo prosthetic joint environment. In this context, the observed phenotypic profiles may represent adaptive bacterial responses to local conditions rather than fixed traits. Future investigations integrating phenotypic analyses with genomic or transcriptomic approaches may help clarify bacterial adaptive responses and phenotypic modulation following exposure to intraoperative antiseptic strategies, complementing the in vitro phenotypic assays used in the present study.
4. Materials and Methods
4.1. Study Design and Clinical Isolate Collection
This observational microbiological investigation prospectively collected intraoperative clinical isolates from patients undergoing RTSA, as previously described [19]. Samples were collected before and after intraoperative irrigation, which was performed using a 0.35% sterile povidone–iodine (Betadine®, Meda Pharma S.p.A., Milan, Italy) solution applied for 3 min. All consecutive isolates recovered during the study period were included in the analysis. Microbial identification was performed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS; Bruker Daltonics GmbH, Bremen, Germany). Clinical isolates were stored at −80 °C and subsequently characterized to detect potential multidrug-resistant bacteria by antimicrobial susceptibility testing and to assess biofilm-forming capability using crystal violet staining.
4.2. Antimicrobial Susceptibility Testing
For frozen C. acnes isolates, susceptibility testing was conducted using the E-test method for aerotolerant anaerobic bacteria according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. Inocula were prepared at a 1.0 McFarland turbidity standard (~3 × 108 CFU/mL) and plated on CDC Anaerobe Agar with 5% sheep blood (BD, Milan, Italy), then incubated at 37 °C under anaerobic conditions for 48 h. The following antimicrobials were assayed: Penicillin G, Ampicillin, Clindamycin, Vancomycin and Meropenem (Biomerieux, Bagno a Ripoli, Florence, Italy).
Aerobic isolates recovered from frozen storage were sub-cultured on Columbia Agar with 5% sheep blood (BD, Milan, Italy) at 37 °C for 18–24 h prior to susceptibility testing with the MicroScan WalkAway system (Beckman Coulter s.r.l., Milan, Italy) using the Positive Combo 33 MicroScan Panel (i.e., Oxacillin, Penicillin, Vancomycin, Teicoplanin, Azithromycin, Clindamycin, Erythromycin, Ciprofloxacin, Levofloxacin, Moxifloxacin, Daptomycin, Trimethoprim/Sulfamethoxazole, Quinupristin/Dalfopristin, Linezolid, Tetracycline, Rifampicin, Gentamicin) for the aerobic Gram-positive bacteria (i.e., CoNS, S. aureus) and the Negative Combo-83 Panel (i.e., Ampicillin, Amoxicillin/Clavulanate, Piperacillin/Tazobactam, Piperacillin, Cefotaxime, Ceftazidime, Cefepime, Ertapenem, Imipenem, Meropenem, Aztreonam, Ciprofloxacin, Levofloxacin, Gentamicin, Amikacin, Tobramycin, Fosfomycin, Chloramphenicol, Colistin, Tigecycline, Trimethoprim/Sulfamethoxazole) for the aerobic Gram-negative bacteria (i.e., E. coli) according to the manufacturer’s instructions. All minimum inhibitory concentration (MIC) results were interpreted in accordance with the guidelines established by the EUCAST (https://www.eucast.org/bacteria/development-of-clinical-breakpoints-and-ecoffs/about-clinical-breakpoints/) (accessed on 22 September 2025).
4.3. Assessment of C. acnes Biofilm Formation
The ability of bacterial isolates to form biofilm was evaluated using the Tissue Culture Plate (TCP) assay [59]. In detail, C. acnes strains were cultured for 72 h at 37 °C in Fluid Thioglycollate Medium (FTM, Merck KGaA, Darmstadt, Germany) to obtain a bacterial suspension with a 1.0 McFarland density. These were then diluted 1:100 in FTM, supplemented with 2% glucose, resulting in a final concentration of approximately 106 CFU/mL. Next, 200 µL of each diluted culture was dispensed into the wells of a 96-well microtiter plate and incubated at 37 °C for 3 and 5 days. After incubation, the supernatant was carefully removed, and each well was rinsed three times with sterile distilled water. The biofilm was fixed with 200 µL of 100% methanol (Carlo Erba Reagents s.r.l., Cornaredo, Milan, Italy) for 15 min. Following methanol removal, 200 µL of 1% crystal violet solution (Merck KGaA, Germany) was added and left for 15 min. Wells were then washed three times with distilled water, air-dried for 1 h, and treated with 200 µL of 95% ethanol to solubilize the stain. Optical density (OD) was measured at 595 nm using a VICTOR3™ microplate reader (PerkinElmer, Hopkinton, MA, USA) [59].
Each strain was tested in ten independent replicates for both incubation times, and mean OD values were calculated. Wells containing only FTM served as negative controls. The cut-off OD (ODc) was defined as three standard deviations above the mean OD of the control. Based on OD measurements, strains were classified according to their biofilm-forming capacity, in terms of adhesion (i.e., the ability of bacterial cells to attach to the substrate and initiate the early aggregate formation steps required for subsequent biofilm development), as reported in Table 4.
Table 4.
Adhesion profile and classification of biofilm production based on optical density (OD) measurements at 595 nm.
| OD Value | Adhesion | Biofilm Production |
|---|---|---|
| OD ≤ ODc | Not adherent | Biofilm non-producer |
| ODc < OD ≤ 2 × ODc | Weakly adherent | |
| 2 × ODc < OD ≤ 4 × ODc | Moderately adherent | Biofilm producer |
| 4 × ODc < OD | Strongly adherent |
Abbreviations: optical density, OD; optical density cut-off value, ODc.
4.4. Assessment of Aerobic Bacteria Biofilm Formation
Biofilm formation was assessed for all aerobic Gram-positive and Gram-negative isolates through the TCP assay. For inoculum preparation, each strain was cultured in Tryptic Soy Broth (TSB, Merck KGaA, Germany) at 37 °C for 18–24 h. Bacterial cells were then suspended in 0.9% sterile NaCl to achieve a turbidity equivalent to a 0.5 McFarland standard and subsequently diluted 1:100 in TSB supplemented with 2% glucose to obtain a final concentration of approximately 106 CFU/mL. A volume of 200 µL of each bacterial suspension was transferred into individual wells of a 96-well microtiter plate, followed by incubation at 37 °C for 24 h. Reference strain S. epidermidis ATCC 12228 strain was used as a negative control. After incubation, the supernatant was carefully removed, and each well was rinsed three times with sterile distilled water. Next, 200 µL of 100% methanol was added. After 15 min, wells were then emptied and stained with 1% crystal violet solution (Merck KGaA, Germany) for 15 min. Plates were washed again three times with sterile distilled water, air-dried for 1 h, and treated with 200 µL of 95% ethanol (Carlo Erba Reagents s.r.l., Italy) to solubilize the dye [59].
Optical density (OD) was measured at 595 nm using a VICTOR3™ microplate reader (PerkinElmer, USA). Each experiment was performed in ten independent replicates per strain, and average OD values were calculated. The cut-off OD (ODc) and biofilm production classification were determined as described above and in Table 4.
4.5. Statistical Analysis
Fisher’s exact test was used to evaluate differences in virulence factors of the strains before and after intraoperative povidone–iodine irrigation. A p-value < 0.05 was considered statistically significant.
5. Conclusions
The shoulder microbiome is distinct, with C. acnes as its predominant component, followed by CoNS—both of which are also the most common pathogens implicated in shoulder PJIs. Intraoperative irrigation with povidone–iodine has been shown to effectively reduce microbial burden in the surgical field. However, the present characterization of a substantial number of strains isolated immediately after the RTSA approach revealed that these bacteria possess virulence factors that may negatively influence patient outcomes following prosthesis implantation. Indeed, a substantial proportion of C. acnes and CoNS isolates were resistant to antimicrobial agents, and many also exhibited a biofilm-forming ability too. Despite these virulence traits, intraoperative povidone–iodine irrigation was associated with a reduction in the number of isolates recovered after irrigation, without an apparent enrichment of antimicrobial-resistant and/or biofilm-forming phenotypes. However, further studies are needed to clarify the direct effects of povidone–iodine and other disinfectants on both anaerobic and aerobic bacteria, in order to determine the most appropriate intraoperative irrigation strategy for minimizing the risk of PJIs in patients undergoing arthroplasty—where both external and internal factors may significantly influence clinical outcomes.
Acknowledgments
The authors are grateful to Tiziana Musso for her valuable collaboration on this work (PNRR Project “One Health Basic and Translational Research Actions Addressing Unmet Needs on Emerging Infectious Diseases”—ACRONYM:INF-ACT-CUP:D53C22002570007).
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics15020129/s1, Table S1: Summary of the biofilm producer and non-producer CoNS isolates, before and after the povidone–iodine irrigation, reported by species.
Author Contributions
Conceptualization, E.B. and V.A.; methodology, F.M. and F.C.; software, A.B. and A.C.; validation, V.A., G.B. and F.C.; formal analysis, N.M.; investigation, E.B., F.L., F.M., R.M., L.M., V.B., H.V. and F.C.; resources, E.B., A.B., A.C. and F.C.; data curation, F.L. and G.B.; writing—original draft preparation, F.L. and V.A.; writing—review and editing, N.M. and G.B.; visualization, N.M. and G.B.; supervision, V.A.; project administration, V.A.; funding acquisition, E.B. and V.A. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
All the data generated or analyzed during this study are included in this published article.
Conflicts of Interest
The authors declare no conflicts of interest.
Funding Statement
Part of the present research was funded by Fondazione CRT (Prof. Valeria Allizond, RF = 106691/2023.1748) and was recognized by the clinical 17th SECEC Research Grant 2023 (Prof. Enrico Bellato).
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Franceschi F., Giovannetti de Sanctis E., Gupta A., Athwal G.S., Di Giacomo G. Reverse Shoulder Arthroplasty: State-of-the-Art. J. ISAKOS Jt. Disord. Orthop. Sports Med. 2023;8:306–317. doi: 10.1016/j.jisako.2023.05.007. [DOI] [PubMed] [Google Scholar]
- 2.Kozak T., Bauer S., Walch G., Al-karawi S., Blakeney W. An Update on Reverse Total Shoulder Arthroplasty: Current Indications, New Designs, Same Old Problems. EFORT Open Rev. 2021;6:189–201. doi: 10.1302/2058-5241.6.200085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Suardi V., Baroni D., Shahein A.H.A., Morena V., Logoluso N., Mangiavini L., Pellegrini A.V. Microbiology of Prosthetic Joint Infections: A Retrospective Study of an Italian Orthopaedic Hospital. Antibiotics. 2024;13:399. doi: 10.3390/antibiotics13050399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Narulla R.S., Chen X., Diwan A.D., Smith G.C.S. The Shoulder Microbiome: A Systematic Review and Meta Analysis. JSES Rev. Rep. Tech. 2024;4:684–693. doi: 10.1016/j.xrrt.2024.06.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Murphy S.C., Russell S.P., Harty J.A., O’Loughlin P. Microbiologic Features of Prosthetic Joint Infections at a Tertiary Referral Orthopaedic Unit. Ir. J. Med. Sci. (1971-) 2025;194:1011–1015. doi: 10.1007/s11845-025-03933-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Longo U.G., Candela V., Facchinetti G., Marchetti A., Dsoke S., Mazzella C., Risi Ambrogioni L., De Marinis M.G., Denaro V. Antibiotic Prophylaxis in Primary and Revision Shoulder Replacement: A Systematic Review. BMC Musculoskelet. Disord. 2020;21:292. doi: 10.1186/s12891-020-03332-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Comini S., Sparti R., Coppola B., Mohammadi M., Scutera S., Menotti F., Banche G., Cuffini A.M., Palmero P., Allizond V. Novel Silver-Functionalized Poly(ε-Caprolactone)/Biphasic Calcium Phosphate Scaffolds Designed to Counteract Post-Surgical Infections in Orthopedic Applications. Int. J. Mol. Sci. 2021;22:10176. doi: 10.3390/ijms221810176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Steixner S.J.M., Spiegel C., Dammerer D., Wurm A., Nogler M., Coraça-Huber D.C. Influence of Nutrient Media Compared to Human Synovial Fluid on the Antibiotic Susceptibility and Biofilm Gene Expression of Coagulase-Negative Staphylococci In Vitro. Antibiotics. 2021;10:790. doi: 10.3390/antibiotics10070790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Allizond V., Comini S., Cuffini A.M., Banche G. Current Knowledge on Biomaterials for Orthopedic Applications Modified to Reduce Bacterial Adhesive Ability. Antibiotics. 2022;11:529. doi: 10.3390/antibiotics11040529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Garvin K.L., Kildow B.J., Hewlett A.L., Hartman C.W., Fey P.D. The Challenge of Emerging Resistant Gram-Positive Pathogens in Hip and Knee Periprosthetic Joint Infections. J. Bone Jt. Surg. Am. 2023;105:878–890. doi: 10.2106/JBJS.22.00792. [DOI] [PubMed] [Google Scholar]
- 11.Foster A.L., Cutbush K., Ezure Y., Schuetz M.A., Crawford R., Paterson D.L. Cutibacterium acnes in Shoulder Surgery: A Scoping Review of Strategies for Prevention, Diagnosis, and Treatment. J. Shoulder Elb. Surg. 2021;30:1410–1422. doi: 10.1016/j.jse.2020.11.011. [DOI] [PubMed] [Google Scholar]
- 12.Parvizi J., Tan T.L., Goswami K., Higuera C., Valle C.D., Chen A.F., Shohat N. The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. J. Arthroplast. 2018;33:1309–1314.e2. doi: 10.1016/j.arth.2018.02.078. [DOI] [PubMed] [Google Scholar]
- 13.Núñez-Pereira S., Benavent E., Ulldemolins M., Sobrino-Díaz B., Iribarren J.A., Escudero-Sánchez R., Del Toro M.D., Nodar A., Sorli L., Bahamonde A., et al. Cutibacterium spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional Study. Antibiotics. 2023;12:518. doi: 10.3390/antibiotics12030518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Blonna D., Allizond V., Bellato E., Banche G., Cuffini A.M., Castoldi F., Rossi R. Single versus Double Skin Preparation for Infection Prevention in Proximal Humeral Fracture Surgery. BioMed Res. Int. 2018;2018:e8509527. doi: 10.1155/2018/8509527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sagkrioti M., Glass S., Arealis G. Evaluation of the Effectiveness of Skin Preparation Methods for the Reduction of Cutibacterium Acnes (Formerly Propionibacterium Acnes) in Shoulder Surgery: A Systematic Review. Shoulder Elb. 2022;14:583–597. doi: 10.1177/17585732211032523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Muwanis M., Barimani B., Luo L., Wang C.K., Dimentberg R., Albers A. Povidone-Iodine Irrigation Reduces Infection after Total Hip and Knee Arthroplasty. Arch. Orthop. Trauma Surg. 2023;143:2175–2180. doi: 10.1007/s00402-022-04451-z. [DOI] [PubMed] [Google Scholar]
- 17.Kułakowski M., Elster K., Szymczak M., Ślęczka P., Baumgart M., Królikowska A., Reichert P. Comparison of the Effect of Combined Usage of Povidone-Iodine Irrigation and Topical Vancomycin Powder to the Use of Povidone-Iodine Irrigation Alone on the Periprosthetic Joint Infection Incidence Rate in Patients Undergoing Primary Total Hip and Knee Arthroplasty: A Protocol for Multicenter Prospective Randomized Clinical Trial. Trials. 2024;25:468. doi: 10.1186/s13063-024-08306-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Cacciola G., Mancino F., Malahias M.A., Sculco P.K., Maccauro G., De Martino I. Diluted Povidone-Iodine Irrigation Prior to Wound Closure in Primary and Revision Total Joint Arthroplasty of Hip and Knee: A Review of the Evidence. J. Biol. Regul. Homeost. Agents. 2020;34:57–62. [PubMed] [Google Scholar]
- 19.Bellato E., Castoldi F., Menotti F., Blonna D., Vasario G., Longo F., Pagano C., Roccavilla M.C., Bondi A., Banche G., et al. Evaluating the Impact of Povidone-Iodine Irrigation on Microbial Contamination in Reverse Total Shoulder Arthroplasty. Bone Jt. Res. 2026. in press .
- 20.Goswami K., Austin M.S. Intraoperative Povidone-Iodine Irrigation for Infection Prevention. Arthroplast. Today. 2019;5:306–308. doi: 10.1016/j.artd.2019.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Baroudi M., Daher M., Parks R.D., Gregoryczyk J.G., Balmaceno-Criss M., McDonald C.L., Diebo B.G., Daniels A.H. Cutibacterium Acnes in Spine Surgery: Pathophysiology, Diagnosis, and Treatment. Spine J. 2024;24:1545–1552. doi: 10.1016/j.spinee.2024.04.018. [DOI] [PubMed] [Google Scholar]
- 22.Ishida N., Nakaminami H., Noguchi N., Kurokawa I., Nishijima S., Sasatsu M. Antimicrobial Susceptibilities of Propionibacterium Acnes Isolated from Patients with Acne Vulgaris. Microbiol. Immunol. 2008;52:621–624. doi: 10.1111/j.1348-0421.2008.00081.x. [DOI] [PubMed] [Google Scholar]
- 23.Boisrenoult P. Cutibacterium Acnes Prosthetic Joint Infection: Diagnosis and Treatment. Orthop. Traumatol. Surg. Res. 2018;104:S19–S24. doi: 10.1016/j.otsr.2017.05.030. [DOI] [PubMed] [Google Scholar]
- 24.Mercieca L., Mangion J., Cefai J., Bezzina T., Schwaiger C., Micallef D., Corso R., Scerri L., Boffa M.J., Caruana P., et al. The Antibiotic Susceptibility Profile of Cutibacterium Acnes in Maltese Patients with Acne. J. Clin. Aesthetic Dermatol. 2020;13:11–16. [PMC free article] [PubMed] [Google Scholar]
- 25.Liu Y., Su Y., Cui Z., Guo Y., Zhang W., Wu J. Clinical and Microbiological Features of Anaerobic Implant-Related Infection in 80 Patients after Orthopedic Surgery. Anaerobe. 2021;71:102413. doi: 10.1016/j.anaerobe.2021.102413. [DOI] [PubMed] [Google Scholar]
- 26.Maraki S., Mavromanolaki V.E., Stafylaki D., Kasimati A. Antimicrobial Susceptibility Patterns of Clinically Significant Gram-Positive Anaerobic Bacteria in a Greek Tertiary-Care Hospital, 2017–2019. Anaerobe. 2020;64:102245. doi: 10.1016/j.anaerobe.2020.102245. [DOI] [PubMed] [Google Scholar]
- 27.Schafer F., Fich F., Lam M., Gárate C., Wozniak A., Garcia P. Antimicrobial Susceptibility and Genetic Characteristics of Propionibacterium Acnes Isolated from Patients with Acne. Int. J. Dermatol. 2013;52:418–425. doi: 10.1111/j.1365-4632.2011.05371.x. [DOI] [PubMed] [Google Scholar]
- 28.Khassebaf J., Hellmark B., Davidsson S., Unemo M., Nilsdotter-Augustinsson Å., Söderquist B. Antibiotic Susceptibility of Propionibacterium Acnes Isolated from Orthopaedic Implant-Associated Infections. Anaerobe. 2015;32:57–62. doi: 10.1016/j.anaerobe.2014.12.006. [DOI] [PubMed] [Google Scholar]
- 29.Wright T.E., Boyle K.K., Duquin T.R., Crane J.K. Propionibacterium Acnes Susceptibility and Correlation with Hemolytic Phenotype. Infect. Dis. 2016;9:39–44. doi: 10.4137/IDRT.S40539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Boattini M., Bianco G., Bastos P., Mavromanolaki V.E., Maraki S., Spiliopoulou A., Kakouris V., Kalchev Y., Budimir A., Bedenić B., et al. Diagnostic and Epidemiological Landscape of Anaerobic Bacteria in Europe, 2020–2023 (ANAEuROBE) Int. J. Antimicrob. Agents. 2025;65:107478. doi: 10.1016/j.ijantimicag.2025.107478. [DOI] [PubMed] [Google Scholar]
- 31.Broly M., Ruffier d’Epenoux L., Guillouzouic A., Le Gargasson G., Juvin M.-E., Leroy A.G., Bémer P., Corvec S. Propionibacterium/Cutibacterium Species–Related Positive Samples, Identification, Clinical and Resistance Features: A 10-Year Survey in a French Hospital. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39:1357–1364. doi: 10.1007/s10096-020-03852-5. [DOI] [PubMed] [Google Scholar]
- 32.Hu L., Fu J., Zhou Y., Chai W., Zhang G., Hao L., Chen J. Trends in Microbiological Profiles and Antibiotic Resistance in Periprosthetic Joint Infections. J. Int. Med. Res. 2021;49:03000605211002784. doi: 10.1177/03000605211002784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Coskun B., Ayhan M., Bozer M., Ozaslan H.I., Dogan M., Citak M., Akkaya M. What Is the Rate of Antimicrobial Resistance of a Prosthetic Joint Infection in a Major Orthopaedic Centre? Antibiotics. 2024;13:306. doi: 10.3390/antibiotics13040306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Mitterer J.A., Frank B.J.H., Gardete-Hartmann S., Panzenboeck L.F., Simon S., Krepler P., Hofstaetter J.G. Changes of the Microbiological Spectrum and Antibiotic Resistance Pattern in Postoperative Spinal Implant Infections with Multiple Culture-Positive Revision Surgeries. Spine J. 2022;22:1934–1943. doi: 10.1016/j.spinee.2022.07.086. [DOI] [PubMed] [Google Scholar]
- 35.Widerström M., Stegger M., Johansson A., Gurram B.K., Larsen A.R., Wallinder L., Edebro H., Monsen T. Heterogeneity of Staphylococcus Epidermidis in Prosthetic Joint Infections: Time to Reevaluate Microbiological Criteria? Eur. J. Clin. Microbiol. Infect. Dis. 2022;41:87–97. doi: 10.1007/s10096-021-04352-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Lourtet-Hascoët J., Félicé M.P., Bicart-See A., Bouige A., Giordano G., Bonnet E. Species and Antimicrobial Susceptibility Testing of Coagulase-Negative Staphylococci in Periprosthetic Joint Infections. Epidemiol. Infect. 2018;146:1771–1776. doi: 10.1017/S0950268818001437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.De Vecchi E., George D.A., Romanò C.L., Pregliasco F.E., Mattina R., Drago L. Antibiotic Sensitivities of Coagulase-Negative Staphylococci and Staphylococcus Aureus in Hip and Knee Periprosthetic Joint Infections: Does This Differ If Patients Meet the International Consensus Meeting Criteria? Infect. Drug Resist. 2018;11:539–546. doi: 10.2147/IDR.S151271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Ortega-Peña S., Franco-Cendejas R., Salazar-Sáez B., Rodríguez-Martínez S., Cancino-Díaz M.E., Cancino-Díaz J.C. Prevalencia y factores de virulencia de Staphylococcus coagulasa negativos causantes de infección de prótesis articular en un hospital ortopédico de México. Cir. Cir. 2019;87:1877. doi: 10.24875/CIRU.19000690. [DOI] [PubMed] [Google Scholar]
- 39.Coenye T., Spittaels K.-J., Achermann Y. The Role of Biofilm Formation in the Pathogenesis and Antimicrobial Susceptibility of Cutibacterium Acnes. Biofilm. 2022;4:100063. doi: 10.1016/j.bioflm.2021.100063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Charalambous L.T., Kim B.I., Schwartz A.M., Case A., Seidelman J.L., Hendershot E.F., Bolognesi M.P., Seyler T.M., Jiranek W.A. Prosthetic Knee Infection with Coagulase-Negative Staphylococcus: A Harbinger of Poor Outcomes. J. Arthroplast. 2022;37:S313–S320. doi: 10.1016/j.arth.2022.02.050. [DOI] [PubMed] [Google Scholar]
- 41.O’Donnell J.A., Wu M., Cochrane N.H., Belay E., Myntti M.F., James G.A., Ryan S.P., Seyler T.M. Efficacy of Common Antiseptic Solutions against Clinically Relevant Microorganisms in Biofilm. Bone Jt. J. 2021;103:908–915. doi: 10.1302/0301-620x.103b5.bjj-2020-1245.r2. [DOI] [PubMed] [Google Scholar]
- 42.Ruchiatan K., Rizqandaru T., Satjamanggala P.R., Tache N., Cahyadi A.I., Rezano A., Gunawan H., Sutedja E.K., Dwiyana R.F., Hidayah R.M.N., et al. Characteristics of Biofilm-Forming Ability and Antibiotic Resistance of Cutibacterium acnes and Staphylococcus epidermidis from Acne Vulgaris Patients. Clin. Cosmet. Investig. Dermatol. 2023;16:2457–2465. doi: 10.2147/CCID.S422486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Scott E., Burkhart C. A Review of the Role of C. Acnes and Its Biofilm in Dandruff Pathogenesis. J. Drugs Dermatol. JDD. 2025;24:566–569. doi: 10.36849/JDD.8648. [DOI] [PubMed] [Google Scholar]
- 44.Hsu J.E., Harrison D., Anderson K., Huang C., Whitson A.J., Matsen F.A., Bumgarner R.E. Cutibacterium Recovered from Deep Specimens at the Time of Revision Shoulder Arthroplasty Samples Has Increased Biofilm-Forming Capacity and Hemolytic Activity Compared with Cutibacterium Skin Isolates from Normal Subjects. J. Shoulder Elb. Surg. 2022;31:318–323. doi: 10.1016/j.jse.2021.07.010. [DOI] [PubMed] [Google Scholar]
- 45.Chen B., Chittò M., Tao S., Wagemans J., Lavigne R., Richards R.G., Metsemakers W.-J., Moriarty T.F. Isolation and Antibiofilm Activity of Bacteriophages against Cutibacterium Acnes from Patients with Periprosthetic Joint Infection. Viruses. 2024;16:1592. doi: 10.3390/v16101592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Santos I.N.M., Kurihara M.N.L., Santos F.F., Valiatti T.B., da Silva J.T.P., Pignatari A.C.C., Salles M.J. Comparative Phenotypic and Genomic Features of Staphylococci from Sonication Fluid of Orthopedic Implant-Associated Infections with Poor Outcome. Microorganisms. 2022;10:1149. doi: 10.3390/microorganisms10061149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Alelign D., Tefera T., Tadesse D., Tessema M., Seid M., Kuwa Y., Aklilu A., Beyene K., Bekele A., Abebe G., et al. Bacteriological Profiles, Antimicrobial Susceptibility Patterns, and Associated Factors in Patients Undergoing Orthopedic Surgery with Suspicion of Surgical Site Infection at Arba Minch General Hospital in Southern Ethiopia. Infect. Drug Resist. 2022;15:2427–2443. doi: 10.2147/idr.s367510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Medis S., Dissanayake T., Kottahachchi J., Namali D., Gunasekara S., Wijesinghe G., Dilrukshi N., Weerasekera M. Biofilm Formation and Antibiotic Resistance among Coagulase Negative Staphylococcus Species Isolated from Central Venous Catheters of Intensive Care Unit Patients. Indian J. Med. Microbiol. 2023;42:71–76. doi: 10.1016/j.ijmmb.2022.10.007. [DOI] [PubMed] [Google Scholar]
- 49.Abdel-Shafi S., El-Serwy H., El-Zawahry Y., Zaki M., Sitohy B., Sitohy M. The Association between icaA and icaB Genes, Antibiotic Resistance and Biofilm Formation in Clinical Isolates of Staphylococci spp. Antibiotics. 2022;11:389. doi: 10.3390/antibiotics11030389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Asante J., Abia A.L.K., Anokwah D., Hetsa B.A., Fatoba D.O., Bester L.A., Amoako D.G. Phenotypic and Genomic Insights into Biofilm Formation in Antibiotic-Resistant Clinical Coagulase-Negative Staphylococcus Species from South Africa. Genes. 2023;14:104. doi: 10.3390/genes14010104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Koch J.A., Pust T.M., Cappellini A.J., Mandell J.B., Ma D., Shah N.B., Brothers K.M., Urish K.L. Staphylococcus Epidermidis Biofilms Have a High Tolerance to Antibiotics in Periprosthetic Joint Infection. Life. 2020;10:253. doi: 10.3390/life10110253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Lin Z.X., Steed L.L., Marculescu C.E., Slone H.S., Woolf S.K. Cutibacterium Acnes Infection in Orthopedics: Microbiology, Clinical Findings, Diagnostic Strategies, and Management. Orthopedics. 2020;43:52–61. doi: 10.3928/01477447-20191213-02. [DOI] [PubMed] [Google Scholar]
- 53.Tevell S., Hellmark B., Nilsdotter-Augustinsson Å., Söderquist B. Staphylococcus Capitis Isolated from Prosthetic Joint Infections. Eur. J. Clin. Microbiol. Infect. Dis. 2017;36:115–122. doi: 10.1007/s10096-016-2777-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Lepelletier D., Maillard J.Y., Pozzetto B., Simon A. Povidone Iodine: Properties, Mechanisms of Action, and Role in Infection Control and Staphylococcus Aureus Decolonization. Antimicrob. Agents Chemother. 2020;64:e00682-20. doi: 10.1128/AAC.00682-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Pichon M., Burucoa C., Evplanov V., Favalli F. Efficacy of Three Povidone Iodine Formulations against Cutibacterium Acnes Assessed through In Vitro Studies: A Preliminary Study. Antibiotics. 2022;11:665. doi: 10.3390/antibiotics11050665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Wan L., Sankaranarayanan J., Lee C.-Y., Zhou H., Yoon T.-R., Seon J.-K., Park K.-S. Povidone-Iodine and Hydrogen Peroxide Combination Improves the Anti-Biofilm Activity of the Individual Agents on Staphylococcus Aureus. Int. J. Mol. Sci. 2025;26:4390. doi: 10.3390/ijms26094390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Barreto R.A., Ribeiro E.R., de Menezes C.L.A., Zaiter M.A., Boscolo M., da Silva R., Gomes E., da Silva R.R. Production and Potential Application of an Alkaline Serine Peptidase from Myceliophtora Heterothallica for Biofilm Removal. Curr. Microbiol. 2025;82:179. doi: 10.1007/s00284-025-04149-6. [DOI] [PubMed] [Google Scholar]
- 58.Roscetto E., Gennaro D.D., Ascione T., Galdiero U., Aversa M., Festa E., Catania M.R., Balato G. Antiseptics’ Concentration, Combination, and Exposure Time on Bacterial and Fungal Biofilm Eradication. Arthroplast. Today. 2024;28:101468. doi: 10.1016/j.artd.2024.101468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Christensen G.D., Simpson W.A., Younger J.J., Baddour L.M., Barrett F.F., Melton D.M., Beachey E.H. Adherence of Coagulase-Negative Staphylococci to Plastic Tissue Culture Plates: A Quantitative Model for the Adherence of Staphylococci to Medical Devices. J. Clin. Microbiol. 1985;22:996–1006. doi: 10.1128/jcm.22.6.996-1006.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All the data generated or analyzed during this study are included in this published article.





